InvestorsHub Logo
Followers 5
Posts 1304
Boards Moderated 0
Alias Born 07/28/2010

Re: drkazmd65 post# 71925

Monday, 09/09/2013 12:05:30 AM

Monday, September 09, 2013 12:05:30 AM

Post# of 146240
you don't need revenue, or even approval, to be given a multi-billion dollar valuation in the market. There are numerous examples. The one that stands out because it goes after a market of similar size (dollar wise) is VRUS which was taken out for $11B pre-revenue with two Hep C drugs just entering Phase III. Of course, NNVC has a platform technology with half a dozen other major candidates in the pipeline to boot. Any valuation post FluCide/Dengue success would have to factor that in as well.


P.S. just for grins... an $11B market cap for NNVC would equate to a stock price of about $68.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News